Comparison of Sequential Fluoroscopy Guidance With Spiral Guidance in Terms of Safety, Effectiveness, Speed and Radiation in Interventional Chest-abdomen-pelvic Procedures

Completed

• Conditions: Body Interventional procédures With CT
• Interventions: Other: Patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control

• Registration Number: NCT03984279
• Lead Sponsor: Centre Hospitalier Universitaire de Besancon

Brief Summary

The purpose of the study was to compare sequential fluoroscopy guidance with spiral guidance in terms of safety (number of major complications), effectiveness (number of targets reached), speed (procedural time) and radiation (DLP) in interventional chest-abdomen-pelvic procedures.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-17
• Primary Completion: 2018-12-31
• Study Completion: 2018-12-31
• Status Verified: 2019-05
• Study First Submitted: 2019-05-27
• Study First Submitted QC: 2019-06-11
• Study First Posted: 2019-06-12
• Last Update Submitted: 2019-07-22
• Last Update Posted: 2019-07-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 385

Inclusion Criteria

• adult patients (> 18 years),
• indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control

Exclusion Criteria

• MRI contra indication
• persons referred to in Articles L1121-5 to L1121-8 of the French Public Health Code

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Siral group (SPI)	Patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control	-
Sequentiel group (SEQ)	Patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control	-

Primary Outcome Measures

Name	Time	Method
number of major complications	All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account	Comparison between the 2 groups
number of targets reached	All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account	Comparison between the 2 groups
Dose Length Product (DLP)	All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account	Comparison between the 2 groups

Secondary Outcome Measures

Name	Time	Method
number of controls required to place the needle	All patients with indication of interventional percutaneous diagnostic or therapeutic chest-abdomen-pelvic procedure under CT control performed on a period of 1 year will be taken into account	Comparison between the 2 groups

Trial Locations

Locations (1)

Centre Hospitalier Universitaire; 🇫🇷 Besançon, France